Carfentanil: A Synthetic Opioid Unlike Any Other
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip
May 14, 2025

Carfentanil: A Synthetic Opioid Unlike Any Other

DEA Headquarters

Fentanyl vs Carfentanil graphic

Over the past two decades, synthetic opioids have increased the threat of the ongoing opioid epidemic. Nearly 70% of all drug poisonings and overdose deaths in 2023 involved synthetic opioids, primarily fentanyl. Also, among these substances is carfentanil, which stands out – at this time – as one of the deadliest fentanyl analogues. This white, powdery drug closely resembles other substances like fentanyl or cocaine, but its danger far exceeds that of nearly any other opioid on the street. 

Carfentanil is a chilling reminder of how the opioid epidemic continues to evolve and introduces new threats at an alarming pace. 

What is Carfentanil?

Carfentanil is a synthetic opioid originally developed for veterinary use, more specifically to tranquilize large animals such as elephants. It is extraordinarily potent and not approved for human use. In fact, it is estimated to be 10,000 times more potent than morphine and 100 times stronger than fentanyl. 

Because of its strength, a nearly microscopic amount of carfentanil can induce a powerful, and often deadly, effect in humans. 

In an effort to increase drug potency and profits, carfentanil has been found mixed with other drugs or pressed into pills that look like prescription painkillers. This increases the likelihood of fatal overdose and poisoning deaths, especially among users who are unaware they are ingesting such a powerful substance.

Increasing Prevalence

DEA, local law enforcement, and first responders have recently seen an increased presence of carfentanil in the illicit drug market, which has been linked to a number of overdose deaths in various parts of the country. According to the CDC, deaths involving carfentanil increased approximately sevenfold – from 29 deaths from January to June 2023, to 238 deaths from January to June 2024. Carfentanil has now been detected in 37 states.

Carfentanil

The current rise in carfentanil prevalence is reminiscent of previous surges observed in late-2016-2017 and 2019-2020. During these periods, the DEA noted significant increases in carfentanil encounters. During this current wave, DEA laboratories have tested more than 100 kilograms of carfentanil mixed with fentanyl, fentanyl-related substances, and other drugs in calendar year 2024 alone. This is larger than the three previous calendar years combined, which totaled approximately 87 kilograms of seized material containing carfentanil. 

The majority of carfentanil seizures throughout 2024 were in a pill or tablet form, not the typical powder form previously encountered. This trend is concerning due to:

  • Increased Risk of Overdose: The extreme potency of carfentanil significantly increases the risk of overdose and death, even with a single pill.
  • Deceptive Appearance: Within the past year, more carfentanil is being pressed into pills that resemble prescription medications, leading to unintentional consumption by individuals who believe they are taking a less potent drug.

Overdose and Treatment Challenges

Exposure to carfentanil can cause respiratory depression or arrest, drowsiness, disorientation, sedation, pinpoint pupils, and clammy skin. The onset of these symptoms usually occurs within minutes of exposure. Its rapid effect on the central nervous system leaves little time for life-saving interventions.

Treating an overdose involving carfentanil is extremely difficult. While naloxone is widely used as an emergency antidote for opioid overdoses, it may not be effective against carfentanil in normal doses. Multiple, high doses of naloxone may be required, and even then, effective reversal of an overdose is not guaranteed.

Raising Awareness and Staying Safe

Public awareness is critical to preventing overdoses and poisonings involving synthetic opioids. Anyone who might encounter illicit substances, including powders and fake pills, should be aware of the potential presence of carfentanil.

Public education and increased awareness are needed to combat the devastating impact of synthetic opioids, like carfentanil.

Remember that One Pill Can Kill. To protect yourself:

  • Avoid Illicit Drugs and Fake Pills: Refrain from using illicit drugs, as they may contain carfentanil without your knowledge. Never take a pill that was not prescribed to you by a doctor and dispensed by a licensed pharmacist.
  • Seek Help: If you suspect someone has been exposed to carfentanil or is experiencing symptoms of overdose, call emergency services immediately and administer naloxone, if available.
  • Stay Informed: Understand the dangers of carfentanil and educate your loved ones about the risks associated with synthetic drugs.

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster